Home   >  
Ion Channel/Membrane Transporter
  • Neuro Signaling Pathway
  • GPCR/G Protein
P2 Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

P2 Receptor

Chemical Structure Cat. No. Product Name CAS No.
PIT Chemical Structure
BCP46868 PIT 56583-49-4
Purinergic P2Y receptor ligand. Displays irreversible antagonism at P2Y receptors in some smooth muscles but potentiates responses to ATP in other systems.
CE-224535 Chemical Structure
BCP46785 CE-224535 724424-43-5
CE-224535 is a Purinergic receptor antagonist originated by Pfizer. Phase-II/III for Rheumatoid arthritis and Phase-II for Osteoarthritis were discontinued.
Eliapixant Chemical Structure
BCP43056 Eliapixant 1948229-21-7
Eliapixant is a purinoreceptor antagonist.
Lu AF27139 Chemical Structure
BCP44190 Lu AF27139 2097117-06-9
Lu AF27139, a novel rodent-active and CNS-penetrant P2X7 receptor antagonist.
JNJ-54166060 Chemical Structure
BCP44118 JNJ-54166060 1627900-42-8
JNJ-54166060 is a potent P2X7 antagonist.
AZ10606120 dihydrochloride Chemical Structure
BCP43716 AZ10606120 dihydrochloride 607378-18-7
AZ10606120 dihydrochloride is a potent, specific P2X7 receptor antagonist that strongly inhibits tumor growth in B16-inoculated C57Bl/6 mice.
2-Methylthioadenosine diphosphate trisodium salt Chemical Structure
BCP42041 2-Methylthioadenosine diphosphate trisodium salt 475193-31-8
2-Methylthioadenosine diphosphate trisodium salt is a potent purinergic agonist displaying selectivity for P2Y1, P2Y12 and P2Y13 receptors (pEC50 = 8.29 and 9.05 for P2Y1 and P2Y12, EC50 = 19 nM for P2Y13).
2-MeS-ADP Chemical Structure
BCP42040 2-MeS-ADP 34983-48-7
2-MeS-ADP is an agonist of P2Y1, P2Y12 and P2Y13 receptors.
MRS 2179 tetrasodium salt Chemical Structure
BCP40607 MRS 2179 tetrasodium salt 1454889-37-2
MRS-2179 tetrasodium salt is a competitive antagonist at P2Y1 receptors that inhibits the upregulation of NTPDase1 by ATPγS.
PSB12062 Chemical Structure
BCP40451 PSB12062 55476-47-6
PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.
123下一页末页共 54 条记录 1 / 6 页